Merkel Cell Carcinoma Clinical Trials

102 clinical trials for Merkel Cell Carcinoma across international registries, including 22 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of CRD3874-SI in People With Solid Tumors — RECRUITING · PHASE1
• A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer — RECRUITING · PHASE1
• The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas — RECRUITING · PHASE2
• Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors — RECRUITING · PHASE1
• Hypofractionated Radiation Therapy for Merkel Cell Carcinoma — RECRUITING · PHASE2
• Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis — RECRUITING · PHASE1
• A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma — RECRUITING · PHASE1
• Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus — RECRUITING · PHASE2
• MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors — RECRUITING · PHASE1
• French National Database of Rare Dermatological Cancers — RECRUITING
• Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer — RECRUITING · PHASE2
• Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype — RECRUITING · NA
• EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers — RECRUITING · PHASE2
• Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma — RECRUITING · PHASE2
• Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma — RECRUITING · PHASE2
• TIL Therapy in cSCC and MCC — RECRUITING · PHASE2
• Personalised Immunotherapy Platform — RECRUITING
• A Beta-only IL-2 ImmunoTherapY Study — RECRUITING · PHASE1
• A RANDOMIZED PHASE 2 STUDY OF ATR INHIBITION IN ADVANCED PD-(L)1-REFRACTORY MERKEL CELL CARCINOMA: THE MATRIX TRIAL — RECRUITING · PHASE2
• A PHASE 1B/2, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OFKRT-232 IN PATIENTS WITH P53 WILD-TYPE (P53WT) MERKEL CELL CARCINOMA (MCC) WHO HAVE FAILED ANTI-PD-1 OR ANTI-PD-L1 IMMUNOTHERAPY, OR IN COMBINATION WITH AVELUMAB IN MCC PATIENTS WHO ARE ANTI-PD-1 OR ANTI-PD-L1 TREATMENT NAÏVE — RECRUITING · PHASE1
• A PHASE 3 OPEN-LABEL, SINGLE ARM STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PEMBROLIZUMAB (MK-3475) AS FIRST-LINE THERAPY IN PARTICIPANTS WITH ADVANCED MERKEL CELL CARCINOMA (KEYNOTE-913) — RECRUITING · PHASE3
• Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers — ACTIVE_NOT_RECRUITING · PHASE2
• Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1 — NOT_YET_RECRUITING · PHASE1
• NeoMatryx - Neoadjuvant Merkel cell carcinoma therapy (Tx) with the PD-1 inhibitor Cemiplimab – A randomized, double-blind, placebo-controlled, non-comparative Phase II study — TERMINATED · PHASE2
• Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO — ACTIVE_NOT_RECRUITING · PHASE3
• In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• SerUM Markers in MERkel Cell Carcinoma Patients: a Longitudinal moniTorIng Study for optiMization of European Guidelines — ACTIVE_NOT_RECRUITING · NA
• A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer — TERMINATED · PHASE2
• Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers — ACTIVE_NOT_RECRUITING · PHASE2
• DOTATOC PET/CT for Imaging NET Patients — ACTIVE_NOT_RECRUITING
• Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies — ACTIVE_NOT_RECRUITING · PHASE1
• Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors — TERMINATED · PHASE1
• Exercise to Boost Response to Checkpoint Blockade Immunotherapy — ACTIVE_NOT_RECRUITING · NA
• Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• Exercise to Boost Response to Checkpoint Blockade Immunotherapy — ACTIVE_NOT_RECRUITING · PHASE1
• Study of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 ) — TERMINATED · PHASE1
• QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors — ACTIVE_NOT_RECRUITING · PHASE2
• Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery — ACTIVE_NOT_RECRUITING · PHASE2
• A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers — TERMINATED · PHASE1
• Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors — COMPLETED · PHASE3
• BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors — TERMINATED · PHASE1
• High-Risk Skin Cancers With Atezolizumab Plus NT-I7 — TERMINATED · PHASE1
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors — TERMINATED · PHASE1
• A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma — ACTIVE_NOT_RECRUITING · PHASE1

Refine this search